NCM
ABBV icon

Northwest Capital Management’s AbbVie ABBV Stock Holding History

Northwest Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,324
Closed -$246K – 254
2025
Q2 		$246K Sell
1,324
-28
-2% -$5.2K 0.13% 99
2025
Q1 		$283K Hold
1,352
– – 0.12% 98
2024
Q4 		$240K Sell
1,352
-75
-5% -$13.8K 0.1% 93
2024
Q3 		$282K Hold
1,427
– – 0.1% 85
2024
Q2 		$245K Sell
1,427
-427
-23% -$70.7K 0.09% 93
2024
Q1 		$338K Hold
1,854
– – 0.11% 85
2023
Q4 		$287K Sell
1,854
-187
-9% -$27.3K 0.1% 89
2023
Q3 		$304K Hold
2,041
– – 0.12% 85
2023
Q2 		$275K Hold
2,041
– – 0.12% 88
2023
Q1 		$325K Buy
2,041
+345
+20% +$52.7K 0.16% 76
2022
Q4 		$274K Sell
1,696
-400
-19% -$61.3K 0.15% 79
2022
Q3 		$281K Buy
2,096
+102
+5% +$14.6K 0.16% 72
2022
Q2 		$305K Sell
1,994
-45
-2% -$6.88K 0.16% 70
2022
Q1 		$331K Sell
2,039
-55
-3% -$7.99K 0.16% 70
2021
Q4 		$295K Sell
2,094
-117
-5% -$13.8K 0.14% 71
2021
Q3 		$241K Sell
2,211
-785
-26% -$89.7K 0.13% 81
2021
Q2 		$348K Buy
2,996
+364
+14% +$41K 0.2% 54
2021
Q1 		$285K Buy
2,632
+12
+0.5% +$1.28K 0.21% 47
2020
Q4 		$281K Buy
2,620
+12
+0.5% +$1.15K 0.21% 51
2020
Q3 		$228K Buy
2,608
+12
+0.5% +$1.13K 0.19% 55
2020
Q2 		$255K Buy
+2,596
New +$229K 0.22% 49

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northwest Capital Management's ABBV Position: Q3 2025 in Review

Northwest Capital Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 1,324 shares — an estimated $246K sold.

Northwest Capital Management first reported a position in ABBV in Q2 2020 and held it in 21 quarters. The position peaked at $348K in Q2 2021. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Northwest Capital Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Northwest Capital Management sold 1,324 AbbVie shares in Q3 2025, an estimated $246K.
  • Northwest Capital Management first reported a position in AbbVie in Q2 2020 and held it in 21 quarters.
  • Northwest Capital Management's AbbVie position peaked at $348K in Q2 2021.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Northwest Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.